Literature DB >> 11266437

Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation.

D K Lee1, H O Duan, C Chang.   

Abstract

Androgen receptor (AR) may communicate with the general transcription machinery on the core promoter to exert its function as a transcriptional modulator. Our previous report demonstrated that the AR interacted with transcription factor IIH (TFIIH) under physiological conditions and that overexpression of Cdk-activating kinase, the kinase moiety of TFIIH, enhanced AR-mediated transcription in prostate cancer cells. In an effort to further dissect the mechanisms implicated in AR transactivation, we report here that AR interacts with PITALRE, a kinase subunit of positive elongation factor b (P-TEFb). Cotransfection of the plasmid encoding the mutant PITALRE (mtPITALRE), defective in its RNA polymerase II COOH-terminal domain (CTD)-kinase activity, resulted in preferential inhibition of AR-mediated transactivation. Indeed, AR transactivation in PC-3 cells was preferentially inhibited at the low concentration of 5,6-dichloro-1-beta-d-ribofuranosylbenzimidazole (DRB), a CTD kinase inhibitor. These results suggest that CTD phosphorylation may play an important role in AR-mediated transcription. Furthermore, a nuclear run-on transcription assay of the prostate-specific antigen gene, an androgen-inducible gene, showed that transcription efficiency of the distal region of the gene was enhanced upon androgen induction. Taken together, our reports suggest that AR interacts with TFIIH and P-TEFb and enhances the elongation stage of transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11266437     DOI: 10.1074/jbc.M002285200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

2.  The transcription elongation factor CA150 interacts with RNA polymerase II and the pre-mRNA splicing factor SF1.

Authors:  A C Goldstrohm; T R Albrecht; C Suñé; M T Bedford; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element.

Authors:  Koh Fujinaga; Dan Irwin; Yehong Huang; Ran Taube; Takeshi Kurosu; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

Review 4.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 5.  Cyclins, cyclin dependent kinases, and regulation of steroid receptor action.

Authors:  N L Weigel; N L Moore
Journal:  Mol Cell Endocrinol       Date:  2007-01-05       Impact factor: 4.102

6.  The transcription-dependent dissociation of P-TEFb-HEXIM1-7SK RNA relies upon formation of hnRNP-7SK RNA complexes.

Authors:  Charlotte Barrandon; François Bonnet; Van Trung Nguyen; Valérie Labas; Olivier Bensaude
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

7.  MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.

Authors:  Annemieke A Michels; Van Trung Nguyen; Alessandro Fraldi; Valérie Labas; Mia Edwards; François Bonnet; Luigi Lania; Olivier Bensaude
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

8.  The positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2.

Authors:  Masanori Nojima; Yehong Huang; Mudit Tyagi; Hung-Ying Kao; Koh Fujinaga
Journal:  J Mol Biol       Date:  2008-07-16       Impact factor: 5.469

9.  CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2.

Authors:  Judit Garriga; Sabyasachi Bhattacharya; Joaquim Calbó; Renée M Marshall; May Truongcao; Dale S Haines; Xavier Graña
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.